Simplex Trading’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-38,200
| Closed | -$87K | – | 9859 |
|
|
2024
Q2 | $87K | Buy |
38,200
+35,200
| +1,173% | +$134K | ﹤0.01% | 5515 |
|
|
2024
Q1 | $12K | Sell |
3,000
-39,600
| -93% | -$138K | ﹤0.01% | 7514 |
|
|
2023
Q4 | $129K | Buy |
+42,600
| New | +$80K | ﹤0.01% | 5121 |
|
|
2023
Q3 | – | Sell |
-700
| Closed | -$1K | – | 10122 |
|
|
2023
Q2 | $1K | Sell |
700
-2,100
| -75% | -$5.74K | ﹤0.01% | 8774 |
|
|
2023
Q1 | $7K | Buy |
2,800
+1,500
| +115% | +$7.21K | ﹤0.01% | 7867 |
|
|
2022
Q4 | $7K | Buy |
1,300
+100
| +8% | +$838 | ﹤0.01% | 7880 |
|
|
2022
Q3 | $14K | Sell |
1,200
-300
| -20% | -$3.43K | ﹤0.01% | 7942 |
|
|
2022
Q2 | $7K | Sell |
1,500
-2,100
| -58% | -$11.6K | ﹤0.01% | 8649 |
|
|
2022
Q1 | $27K | Sell |
3,600
-4,500
| -56% | -$42.7K | ﹤0.01% | 7916 |
|
|
2021
Q4 | $82K | Sell |
8,100
-13,300
| -62% | -$169K | ﹤0.01% | 6550 |
|
|
2021
Q3 | $480K | Hold |
21,400
| – | – | ﹤0.01% | 4165 |
|
|
2021
Q2 | $469K | Buy |
21,400
+21,130
| +7,826% | +$469K | ﹤0.01% | 4266 |
|
|
2021
Q1 | $649K | Buy |
270
+163
| +152% | +$3.79K | ﹤0.01% | 2981 |
|
|
2020
Q4 | $192K | Buy |
+107
| New | +$1.6K | ﹤0.01% | 4662 |
|
|
2019
Q4 | – | Sell |
-11
| Closed | -$25K | – | 8128 |
|
|
2019
Q3 | $25K | Buy |
+11
| New | +$347 | ﹤0.01% | 5658 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | -$1K | – | 8043 |
|
|
2018
Q4 | $1K | Buy |
+1
| New | +$37 | ﹤0.01% | 6816 |
|
Simplex Trading's GTHX Position: Q1 2024 in Review
Simplex Trading sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 233,626 shares — an estimated $814K sold.
Simplex Trading first reported a position in GTHX in Q4 2018 and held it in 15 quarters. The position peaked at $712K in Q4 2023. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.
- Simplex Trading reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 233,626 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $814K.
- Simplex Trading first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2018 and held it in 15 quarters.
- Simplex Trading's G1 Therapeutics, Inc. Common Stock position peaked at $712K in Q4 2023.
- 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.